Patient Information on the KRAS-variant found in 20 percent of breast cancer patients.

1. Uniting Patients with Novel Genetic Discoveries toTransform Health
Do you have a personal or family history
of breast, ovarian, or lung cancer?
Have you or someone in your family been
diagnosed with two independent cancers?
Have you been diagnosed
with endometriosis?
The KRAS-variant
is found in
of the world’s population
and up to
of women with
breast or ovarian cancer
If so, you may want to learn more about the KRAS-
variant, an inherited, genetic mutation that provides
powerful information to help direct prevention
strategies, cancer screenings, and, ultimately, personalized
treatment. By providing a simple cheek swab, you
can learn your KRAS-variant status through a
physician of your choice.

2. Founded by Joanne Weidhaas, MD, PhD, MSM,
MiraKind conducts patient-centric research to
unite patients with groundbreaking genetic research
to advance the prevention and treatment of disease.
MiraKind personalizes actionable approaches based
on each individual’s unique genetic makeup.
We invite you to get involved in our community by
participating in research studies, supporting our work,
and helping to spread the word to all those who
might like to get involved in or may benefit from our
mission.
Visit us online at MiraKind.org
PO Box 952
Menlo Park, CA 94026
MiraKind.org
info@MiraKind.org
Learn more about how we can
work together to advance
the prevention and treatment
of cancer and endometriosis
facebook.com/MiraKind.org
@Mira_Kind